KVUE vs PBH
KVUE: Kenvue is a pure-play consumer health giant managing a portfolio of iconic, science-backed brands across personal care, skin health, and essential household wellness products. PBH: Prestige Consumer Healthcare is a branded OTC healthcare company that manages a diverse portfolio of essential household and personal care products.
Side-by-side fundamentals
| Metric | KVUE | PBH | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $19.04 | $47.92 | |
| Market cap as of 2026-07-31 (share count; price 2026-10-21) | $36.6B | $2.3B | |
| P/E as of 2026-10-21 | 22.40 | 13.42 | PBH lower |
| Net margin | +9.7% | +17.5% | PBH higher |
| Gross margin | +58.1% | +54.7% | KVUE higher |
| Operating margin | +16.0% | +28.4% | PBH higher |
| ROE | +13.7% | +10.1% | KVUE higher |
| ROA | +5.4% | +5.4% | PBH higher |
| Debt / equity | 0.80 | 1.05 | KVUE lower |
| Revenue growth (YoY) | -2.1% | -4.3% | KVUE higher |
| Revenue CAGR (3y) SEC XBRL | +0.2% | -1.2% | KVUE higher |
| Dividend yield as of 2026-09-02 | +4.7% | n/a | |
| Dividend streak (yrs) SEC XBRL | 3 | 0 | KVUE higher |
| Beta as of 2026-09-02 | 0.18 | 0.39 | |
| 1-year return as of 2026-10-21 close | +27.5% | -23.3% | KVUE higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.